To identify molecular markers with predictive value for the progression of superficial bladder cancer we used the differential hybridization analysis approach. Since primary tumor material is heterogeneously composed of subpopulations that are poorly characterized, we used in this study a rat progression model system that phenotypically and cytogenetically resembles human superficial bladder cancer. In the differential hybridization analysis we compared the mRNA populations of low and high metastatic tumor lines. We observed an overexpression of ferritin Heavy chain (ferritin H) in the tumor line with the lower metastatic capacity and better differentiated phenotype. The exact clinical relevance for the differential expression of ferritin H in human bladder cancer remains to be determined.
Introduction
An important issue in the management of superfi cial transitional cell carcinoma (TCC) of the bladder is to identify those patients that are at risk for pro to invasive disease. Since primary tumor material is usually heterogeneously composed of sub populations are poorly characterized, it is not suitable to identity TCC progression markers. The identification of such requires a tumor model system in which the different stages of tumor progression are represented.
In this study a rat bladder tumor model system (RBT) is used that phenotypically and cytogenetically resembles human superficial TCC [1] . Two sponta neously arisen bladder tumors (in ACI rats) RBT 323 and RBT 157, were serially transplanted. In the fifth transplant generation the RBT 323 becomes metastatic to the lungs in more than 90% of animals. The metastatic ability of the RBT 157 tumor changes from low to intermediate (50% of the rat have lung metastases) in the fourth passage. The tumor doubling time of the RBT 323 tumor decreased from 13 days to 3.5-4 days, while the tumor doubling time of the RBT 157 tumor remained almost unchanged. Both tumor lines initially resembled grade II TCC. How ever, while the histological pattern of the RBT 157 remained essentially unchanged, the RBT 323 tumor progressed to a grade III tumor in the third passage [1]. In order to identify genes that are associated with the progression of superficial bladder cancer we apysis to compare the mRNA levels of the RBT 323 with the RBT 157 line, two lines that differ in their metastatic capacity. The cDNA clones that detected differentially expressed genes were further evaluated for their relationship to the metastatic phenotype by means of Northern blot analyses. The cDNA clones of interest were sequenced and the resulting nu cleotide sequences were compared to nucleotide database to search for homology with known genes.
Materials and methods

Tumor specimens
Tumor material from a rat bladder tumor model system (RBT) [1] was used in this study (Table 1) . Transplant passage #10 of the highly metastatic line RBT 323 and passage #1 of the moderate metastatic line RBT 157 were used for the differential hy- bridization experiments. In order to check the rele vance of the selected clones passages 1, 2, 8, 9, 15 and 16 of the RBT 323 line and passage 1 and 6 of the RBT 157 line were used.
Construction of cDNA libraries
A directionally cloned cDNA library was con structed using polyadenylated cytoplasmic RNA from the highly metastatic RBT323 line, passage #10. Poly(A + )RNA (5 /xg) was fractionated from total RNA by oligo(dT)-cellulose chromatography and to tal RNA was isolated using the lithium chloride/urea procedure [2] . First strand cDNA was synthesized by using an oligo(dT) primer-adaptor (Promega) contain ing a NOT-1 site 5' to the oligo(dT) tail. Second strand cDNA synthesis was performed using the pro cedures described by Gubler and Hofman [3] . The cDNA was blunt ended by using T4-DNA poly merase (10 U). After purification using micro collo dion bags (Sartorius GmbH), EcoRl linkers (1 /ng, Stratagene) were ligated to the blunt ended cDNA by means of T4-DNA ligase, followed by digestion with NOT-1 and EcoRl restriction endonucleases. The digested linkers were separated from the cDNA by means of PurElute™ agarose gel electrophoresis (Invitrogen) and the cDNAs with the desired size range (0.5-10 kb) were isolated from the agarose. Electroe lution of the cDNA from the agarose was performed using the Geneluter™ electroelution system (Invitrogen). Subsequently the ds cDNA was ligated in the Lambda Zap-II cloning vector (Stratagene), inserted into the phage particles using Promega Packagene Lambda DNA Packaging System and transformed to XL-1 Blue E. coli bacteria.
Differential screening o f the cDNA library
For the differential screening of the RBT 323/10 cDNA library, 36000 recombinant phages were plate were taken on nitrocellulose by incubation dur ing 1, 3, 10 and 30 min, respectively. The filters were next lysed according to Sambrook et al. [4] . Hy bridization was performed according to Hanahan and Meselson [5] in 40% formamide at 42°C during 60 hours. For the differential screening, probes represen tative for the RBT 323/p a ss ■ 10 and RBT 157/pass 
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overexpressed in the RBT 157 line. These 22 selected cDNA clones were further evaluated using Northern blots containing 10 pug of RBT 157/1, RBT 3 2 3 /1 and RBT 3 2 3 /1 0 RNA. The expression pattern of the most significant clone pV13 is shown in Fig. 2A .
Differential screening 3.2. Expression pattern o f pV13
A cDNA library was constructed from the mRNA of the highly metastatic line R B T 323/p a ssa g e 10.
The complexity of the library was 4.3 • 105 recombi nant clones and 36000 recom binant phages from the ( Fig. 2A) . The correlation of clone pV13 expression Clone pV13, is clearly overexpressed in RBT 157/1, the line with the lowest metastatic capacity. pV13 detects a single transcript of approx. 1.1 kb primary library were plated. Replica filters were dif ferentially screened using radioactively labeled cDNA with metastatic capacity was further studied by means of Northern blot analysis of more passages of the rat probes derived from p o ly -A + RNA o f the RBT progression model (Fig. 2B) . The passages 1 and 6 of 323/pass.lO (high m etastatic ) and the RBT the RBT 157 line, with the moderate metastatic ca-157/pass.l (low metastatic). Extensive comparison pacity, show both an higher expression level of pV 13 of the resulting autoradiogram s (Fig. 1 ) revealed 22 cDNA clones that seem ed to be differentially ex compared to the tested passages of the RBT 323 line, with the high metastatic capacity. As a control we lower panel (B) ). studied the expression of pV13 in Dunning R-3327 rat prostatic tumors [8] and in normal rat prostate (in correlation between ferritin H expression and a num ber of differentiation shown by others normal bladder insufficient RNA was isolated from [18, 19] , is corroborated in this study by the overexthe tiny layers of urothelium). The higher expression of pV13 in the sublines with lower metastatic capac ity, as seen for the bladder tumor model system, was confirmed and in normal rat prostate no expression of pV13 was observed (data not shown).
DNA sequence analysis of pV13
pression of ferritin H in the better differentiated tumor line RBT 157. In smooth muscle cells it is proposed that cAMP promotes ferritin H expression resulting in both growth arrest and an enhanced differentiated phenotype [20] .
The exact biological consequences of altered fer ritin subunit composition are not well understood. It
To obtain further information on the cDNA clone, the nucleotide sequences were determined using the Sequenase Version 2.0 sequence system. Computerassisted comparison of the resulting nucleotide se-may result in modulation of the iron binding capacity of ferritin and ultimately, the regulatory pools of free iron [21, 11] . An enrichment for the ferritin H subunit leads to more efficient iron detoxification and cellular protection against free formation [22] . Anquences with the EMBL and Gen bank nucleotide other mechanism underlying the regulation of ferritin sequence databases revealed that p V 13 is highly ho mologous to the Rat Ferritin Heavy chain gene (97%) [9] and the Mouse Ferritin Heavy chain (94%) [10] . expression has been extensively studied and is ex erted posttranscriptionally by specific mRNA-protein interaction between the iron-regulating protein (IRE BP) and Iron-Responsive Elements (IREs) contained in the 5 'untranslated region of ferritin. Iron inacti-
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vates the cytoplasmic IRE-BP, thereby preventing its
In search of new molecular markers with predic tive value for the progression of superficial TCC, we binding to the IRE and consequently derepressing ferritin translation [23] .
It should be emphasized that the mechanisms uncompared two different tumor lines of a rat TCC derlying the altered subunit composition of ferritin in model system at the level of gene expression using differential hybridization analysis. We observed an overexpression of ferritin H in the RBT 157 tumor line which displays the lowest metastatic capacity and the best differentiated phenotype.
Ferritin H combines with the ferritin L subunit to neoplastic cells are not elucidated. Ferritin H is lo cated on human chromosome 11 [24] , near 11 q 13 [25] , a region that is sometimes amplified in bladder cancer [26] . We have determined that the ferritin H gene is not within the i shown).
on 11 q 13 (data not form the iron storage protein ferritin [11] . Ferritin Cytogenetic analysis of the RBT lines showed that H-rich molecules take up and release iron more read ily than L-rich molecules, that are more suited for long-term storage [12] . A relationship between fer-both of the independently arisen tumors exhibit loss of chromosome 5 [1]. Rat chromosome 5 is syntenic to the major portion of human chromosome 9 (p23ritin and cancer been since serum qter) a chromosome that is commonly lost in human ferritin is frequently elevated in patients with cancer [13, 14] . Some neoplastic cells also exhibit a remark-TCC. The more RBT 323 has considerably more cytogenetic changes compared to ably altered ferritin subunit composition (i.e enrich ment for the heavy chain subunit) as compared to their normal counterparts [15, 16] . A direct association RBT 157. Due to the fact that the nomic map of human and rat is rather restricted [27] it is difficult to speculate about the potentially between oncogenic transformation and ferritin syn-relevant to the observed cytogenetic changes thesis has been suggested, since the adenovirus E l A oncogene specifically represses ferritin H expression [17] . The observed down regulation of ferritin H expression in the more malignant tum or line RBT 323 is in concordance with this observation. The
Our findings show a correlation of ferritin H over expression with lower metastatic capacity and better differentiated phenotype in a rat bladder tumor model system. We are currently investigating the value of differential exoression of ferritin H as a prognostic marker in human bladder cancer using quantitative comparative Polymerase Chain Reaction.
